VAERS Explorer
Back to explore

Report #2853460

Received Aug 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
6 yrs
State
TX
Recovered
Recovered
Vaccinated
Aug 9, 2025
Onset
Aug 9, 2025
Days to onset
0
Hospital days
—

Vaccines (3)

TypeNameManufacturerDoseLotRoute / Site
DTAPIPVDTAP + IPV (KINRIX)GLAXOSMITHKLINE BIOLOGICALS352D72IM / RA
HEPAHEP A (HAVRIX)GLAXOSMITHKLINE BIOLOGICALS1DN273IM / LA
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.1Z008501SC / LA

Symptoms (1)

Dizziness

Symptom narrative

Patient Presentation & Pre-Vaccination Assessment: Patient presented accompanied by her parents and sister for immunizations. Full name and date of birth were verified. Screening for allergies to medications, vaccines, or foods, as well as any underlying medical conditions or contraindications, was negative per the mother. Last food intake was breakfast. The patient appeared slightly anxious after observing her sister experience dizziness earlier during vaccination. She was reassured and encouraged to remain calm. After reviewing the patient?s vaccination record, it was determined that 5 vaccines were due: Hepatitis A, DTaP?Polio, and MMRV (3 injections total). The mother was informed of the vaccines and potential adverse reactions, and was provided with Vaccine Information Statements in (withheld). She verbalized understanding and signed informed consent. Vaccination Administration: Vaccines were administered as indicated. Adverse Event: At 15:30, immediately after vaccine administration, the patient reported feeling dizzy. She was placed in a supine position with legs elevated, and an alcohol pad was provided for inhalation. The patient was not pale and did not lose consciousness. Initial vital signs: BP 90/72 mmHg, HR 105 bpm, SpO2 99%, RR 31/min, Temp 97.1°F. She was monitored for 15 minutes, during which she reported feeling better, though she appeared apprehensive. Monitoring & Outcome: At 15:40, vital signs were: BP 98/76 mmHg, HR 100 bpm, SpO2 99%, RR 20/min, Temp 97.7°F. The patient was alert, conscious, oriented, and conversing with her parents. She was instructed to remain seated under observation. After an additional 5 minutes of monitoring, the patient ambulated from the area without complications, accompanied by her parents and sister.

Current illness

None

Medical history

None

Other medications

None

Allergies

None

Lab data

None